DONATE

Search Results for:

IBEC promotes the development of advanced therapies thanks to FEDER funding

Funding from the 2014-2020 Catalan FEDER Operational Program, through the call for institutional projects for R+D infrastructure with a total amount of 700,000€, has co-financed the adaptation of new laboratory spaces and the acquisition of scientific equipment for IBEC laboratories. These new infrastructures will be aimed at boosting nanomedicine and tissue engineering research for the development of advanced therapies.

The intestinal organoids hit the media

The group led by Xavier Trepat at IBEC, together with Marino Arroyo, associate researcher at IBEC, and other international collaborators have developed intestinal organoids and measured cellular forces in order to decipher how the inner wall of this vital organ folds and moves.

PhD Thesis Defence: Ferran Velasco

Carboxymethyl cellulose-based cryogels as scaffolds for pancreatic and skeletal muscle tissue engineering Ferran Velasco, Biosensors for bioengineering group The defence will take place online, if you wish to attend to … Read more

Postdoctoral researcher at the Biomedical Signal Processing and Interpretation Research Group

Application Deadline: 29/06/2021
Ref: PD-RJ

The Biomedical signal processing and interpretation group at the Institute for Bioengineering of Catalonia (IBEC) is looking for Postdoctoral Researcher on Multimodal Biomedical Signal Processing. The contract will be within the framework of the project “Smart health ecosystem (tools, apps and devices) for personalized medicine and Healthcare in REspiratory diseases and Sleep disorders (SappHiRES)”, financed by MCIU/AEI/FEDER.

PhD Thesis Defence: Maria Arista

Unveiling viral structures by single-molecule localization microscopy Maria Arista, Nanoscopy for nanomedicine group The defence will take place online, if you wish to attend to this defence, you can find … Read more

Controlling brain states with a ray of light 

A study led by researchers from IBEC and IDIBAPS achieves, for the first time, the control of brain state transitions using a molecule responsive to light, named PAI.  The results not only pave the way to act on the brain patterns activity, but they also could lead to the development of photomodulated drugs for the treatment of brain lesions or diseases such as depression, bipolar disorders or Parkinson’s or Alzheimer’s diseases. 

© 2026 Institute for Bioengineering of Catalonia